Funder
Belgian government agency for Innovation by Science and Technology
Fund for Scientific Research Flanders
Clinical Research Fund of the University Hospitals Leuven
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference23 articles.
1. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013–22.
2. Malik M, Hnatkova K, Kowalski D, Keirns JJ, van Gelderen EM. Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval. J Electrocardiol. 2012;45:571–81.
3. Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;. doi:10.1161/JAHA.116.003264.
4. CPMP/986/96. The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: Committee for Proprietary Medicinal Products; 1997.
5. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol. 2006;17:333–6.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献